Coya Therapeutics, Inc.
COYA$89M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaHOUSTON8 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Aug 11, 2026
7wMarket Overview
Stock performance and key metrics
COYA News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
COYA 302 | Phase 2 | Amyotrophic Lateral Sclerosis (ALS) | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply